FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040468312> ?p ?o ?g. }

• W3040468312 endingPage "5463" @default.
• W3040468312 startingPage "5454" @default.
• W3040468312 abstract "Changes in pneumococcal antimicrobial resistance (AMR) have been reported following use of pneumococcal conjugate vaccines (PCVs) in childhood vaccination programmes. We describe AMR trends and clonality in Norway during 2004–2016; we studied 10,239 invasive pneumococcal disease (IPD) isolates in terms of serotypes, antimicrobial susceptibility, and for a systematically collected subset of 2473 isolates, multilocus sequence types (ST). The IPD cases were notified to the Norwegian Surveillance System for Communicable Diseases and pneumococcal isolates were collected through the National Reference Laboratory for Pneumococci. The cases are sourced from the entire Norwegian population. We supplemented the IPD isolates with isolates from carriage studies in children attending day-care, performed in 2006 (before mass childhood vaccination with PCV7), 2008 (2 years after PCV7 introduction), 2013 (2 years after the transition to PCV13), and 2015. IPD cases were 0–102 years old; median 64 years. Carriage study participants were typically aged 1–5 years. Overall, AMR was low; a maximum of 7% of IPD isolates were resistant, depending on the antimicrobial. Erythromycin and trimethoprim/sulfamethoxazole resistant IPD (ERY-R and SXT-R, respectively) decreased in the PCV7 period (2006–2010). In the PCV13 period (2011–2016) however, we saw an indication of increased non-susceptibility among IPD isolates. This increase was mainly due to non-vaccine serotypes 15A-ST63 (multidrug resistant), 24F-ST162 (SXT-R), 23B-ST2372 (penicillin non-susceptible and SXT-R) and 33F (ERY-R and clindamycin resistant). Resistant or non-susceptible IPD isolates were often clones introduced into Norway during the study period. The exception was ERY-R isolates; initially, these largely consisted of an established serotype 14-ST9 clone, which disappeared after introducing PCV7. The carriage study results mostly resembled the changes seen in IPD with a maximum of 9% of the participants per study carrying resistant pneumococci. As actual PCVs are not fully limiting AMR, higher-valency vaccines and prudent use of antimicrobials are still needed to temper pneumococcal AMR." @default.
• W3040468312 created "2020-07-10" @default.
• W3040468312 creator A5009940787 @default.
• W3040468312 creator A5033248082 @default.
• W3040468312 creator A5051895529 @default.
• W3040468312 creator A5065596492 @default.
• W3040468312 creator A5074263116 @default.
• W3040468312 date "2020-07-01" @default.
• W3040468312 modified "2023-09-30" @default.
• W3040468312 title "Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004–2016" @default.
• W3040468312 cites W1794883157 @default.
• W3040468312 cites W1971205889 @default.
• W3040468312 cites W1987330843 @default.
• W3040468312 cites W2000499723 @default.
• W3040468312 cites W2016570316 @default.
• W3040468312 cites W2035758731 @default.
• W3040468312 cites W2051039256 @default.
• W3040468312 cites W2063558597 @default.
• W3040468312 cites W2063701791 @default.
• W3040468312 cites W2071452243 @default.
• W3040468312 cites W2092280458 @default.
• W3040468312 cites W2097362862 @default.
• W3040468312 cites W2115938372 @default.
• W3040468312 cites W2121369371 @default.
• W3040468312 cites W2134606926 @default.
• W3040468312 cites W2138607660 @default.
• W3040468312 cites W2163578831 @default.
• W3040468312 cites W2296086209 @default.
• W3040468312 cites W2341199367 @default.
• W3040468312 cites W2342686378 @default.
• W3040468312 cites W2400831038 @default.
• W3040468312 cites W2410910356 @default.
• W3040468312 cites W2523202475 @default.
• W3040468312 cites W2554376622 @default.
• W3040468312 cites W2563365353 @default.
• W3040468312 cites W2579828308 @default.
• W3040468312 cites W2613751645 @default.
• W3040468312 cites W2735385734 @default.
• W3040468312 cites W2884426126 @default.
• W3040468312 cites W2891849294 @default.
• W3040468312 cites W2904099054 @default.
• W3040468312 cites W2904457533 @default.
• W3040468312 cites W2950614621 @default.
• W3040468312 cites W2971512242 @default.
• W3040468312 cites W3000570230 @default.
• W3040468312 cites W3012588447 @default.
• W3040468312 cites W3025052867 @default.
• W3040468312 cites W4243398387 @default.
• W3040468312 doi "https://doi.org/10.1016/j.vaccine.2020.06.040" @default.
• W3040468312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32616324" @default.
• W3040468312 hasPublicationYear "2020" @default.
• W3040468312 type Work @default.
• W3040468312 sameAs 3040468312 @default.
• W3040468312 citedByCount "17" @default.
• W3040468312 countsByYear W30404683122020 @default.
• W3040468312 countsByYear W30404683122021 @default.
• W3040468312 countsByYear W30404683122022 @default.
• W3040468312 countsByYear W30404683122023 @default.
• W3040468312 crossrefType "journal-article" @default.
• W3040468312 hasAuthorship W3040468312A5009940787 @default.
• W3040468312 hasAuthorship W3040468312A5033248082 @default.
• W3040468312 hasAuthorship W3040468312A5051895529 @default.
• W3040468312 hasAuthorship W3040468312A5065596492 @default.
• W3040468312 hasAuthorship W3040468312A5074263116 @default.
• W3040468312 hasBestOaLocation W30404683121 @default.
• W3040468312 hasConcept C10389963 @default.
• W3040468312 hasConcept C104317684 @default.
• W3040468312 hasConcept C135763542 @default.
• W3040468312 hasConcept C142724271 @default.
• W3040468312 hasConcept C159047783 @default.
• W3040468312 hasConcept C174802600 @default.
• W3040468312 hasConcept C187212893 @default.
• W3040468312 hasConcept C22070199 @default.
• W3040468312 hasConcept C2776152631 @default.
• W3040468312 hasConcept C2777458120 @default.
• W3040468312 hasConcept C2778866548 @default.
• W3040468312 hasConcept C2780206985 @default.
• W3040468312 hasConcept C2780728791 @default.
• W3040468312 hasConcept C2781253189 @default.
• W3040468312 hasConcept C2908647359 @default.
• W3040468312 hasConcept C32762888 @default.
• W3040468312 hasConcept C501593827 @default.
• W3040468312 hasConcept C55493867 @default.
• W3040468312 hasConcept C71924100 @default.
• W3040468312 hasConcept C77434933 @default.
• W3040468312 hasConcept C86803240 @default.
• W3040468312 hasConcept C89423630 @default.
• W3040468312 hasConcept C94665300 @default.
• W3040468312 hasConcept C99454951 @default.
• W3040468312 hasConceptScore W3040468312C10389963 @default.
• W3040468312 hasConceptScore W3040468312C104317684 @default.
• W3040468312 hasConceptScore W3040468312C135763542 @default.
• W3040468312 hasConceptScore W3040468312C142724271 @default.
• W3040468312 hasConceptScore W3040468312C159047783 @default.
• W3040468312 hasConceptScore W3040468312C174802600 @default.
• W3040468312 hasConceptScore W3040468312C187212893 @default.
• W3040468312 hasConceptScore W3040468312C22070199 @default.
• W3040468312 hasConceptScore W3040468312C2776152631 @default.

• next